Study Show Avandia Creates Higher Risks
A new study led by a federal drug safety expert ties the diabetes drug Avandia to a higher risk of heart problems, strokes and deaths in older adults and says it is more dangerous than a rival drug, Actos.
The study, a huge review of Medicare records, comes two weeks ahead of a Food and Drug Administration hearing on Avandia’s safety.
The lead author, Dr. David Graham, is an FDA scientist who wants the pill banned.
As many as 100,000 heart attacks, strokes, deaths and cases of heart failure may be due to Avandia since it came on the market in 1999, Graham said.















